Fungal infection can be both superficial and can also penetrate deep inside the body. They trigger the immune system causing inflammation or tissue damage. Both the topical treatment and drugs are used to treat these infections. This session deals with all those aspects related to fungal infections
The global antifungal drugs market size was valued at USD 11.3 billion in 2017. Raising prevalence of fungal infections such as Aspergillosis and Candidiasis is the key factor propelling the market. Global Antifungal Drugs Market is predicted to rise from 13,719 USD million in 2016 to 17,718 USD million by 2023. The industry is anticipated to register a CAGR of 3.7%, during the forecast period of 2017 - 2023.
ALSO READ Infectious Diseases and Global Health Viral Infections Bacterial Infections Fungal Infections Vector-borne Diseases Virology and HIVAIDS Immunology and Clinical Microbiology Neurological and CNS Infections Healthcare-Associated Infections Ophthalmological Infectious Diseases Vaccines and Immunizations Tropical Diseases and Parasitic Diseases Sexually Transmitted Diseases and STIs Lower Respiratory and Pediatric IDs Pathophysiology and Diagnosis Clinical Trials and Case Studies Influencing Factors of IDs Advanced Treatments and Technologies Prevention and Control Public Health and Epidemiology Oral and Maxillofacial Infections Genomics and Infectious disease Special Session on COVID-19
Infection Prevention & Control Conferences Asia Vaccines conferences Infection Prevention Conferences 2022 Infectious Diseases Conferences 2022 Epidemiology Conferences 2022 Virology Conferences Healthcare Conferences Communicable Diseases Conferences 2022 HIV/AIDS conferences Hepatitis Conferences Paediatric Infectious Diseases Conferences Infectious Diseases Conferences Infection Control Conferences Influenza Conferences Epidemiology Conferences